https://www.youtube.com/channel/UC-O3rHG8SOJUhw7xsN3l5TA OAKLAND, Calif. – Albert, which has built the first chemistry-native AI operating system for R&D, today announced a $55 million Series B led by TCV with participation from new investors Delta-v Capital, Socium Ventures, HighSage Ventures, Coral Capital, and Legion VC. They are joined by existing investors Coatue, J.P. Morgan Growth Equity Partners, Index [...]

PELHAM, NH, UNITED STATES -- Analytics By Light today announced its incorporation in Delaware as Analytics By Light, Inc. and has appointed co- founder Phillip Maderia President and Chief Executive Officer. The company is developing theµImager™ platform to give bioreactors continuous, in-situ visibility of cell morphology as the process unfolds. Conventional process analytical technology monitors [...]

WASHINGTON -- Danaher Corporation (NYSE: DHR) ("Danaher" or "the Company") today announced the appointment of Daniel L. Comas and Robert Hershberg, M.D., Ph.D., to the Danaher Board of Directors on October 9, 2026. Dr. Hershberg has also been appointed to the Company's Science and Technology Committee. Alan G. Spoon will not stand for reelection at Danaher's [...]

Ahlstrom and Hamilton collaborate to advance fully automated Dried Blood Spot sample processing Bonaduz, Switzerland - Ahlstrom, a global leader in fiber-based specialty materials, and Hamilton AG are collaborating to drive the next generation of laboratory automation for Dried Blood Spot (DBS) sample processing. This collaboration combines Ahlstrom’s proven specimen collection solutions with the Hamilton [...]

Malvern Panalytical, a market-leader in material characterization technologies, today (October 9) announces the acquisition of Dimer Instruments – a developer of cutting-edge technologies for biopharmaceutical analysis. Headquartered in Santa Barbara, CA, Dimer Instruments was founded by industry veterans Dr. Stephen Minne and Dr. Michael Larkin, who bring deep expertise in biophysical characterization and analytical instrumentation. Malvern [...]

Shimadzu Corporation has started the development and validation of a mass spectrometry solution for core laboratories at St. Vincent’s Hospital in Melbourne, Victoria, Australia. Shimadzu’s LC-MS-based automation solution has been integrated with Abbott Laboratories’ AlinIQ AMS laboratory informatics solution to streamline and automate clinical testing workflows in core laboratories. The solution is being developed and [...]

Investment strengthens Bio-Techne's global GMP manufacturing infrastructure for cell therapy applications New Bristol facility expands GMP small molecule production capacity and complements recent investments in North America Combined capabilities across Bristol, St. Paul and Minneapolis support customers from discovery through commercial manufacturing MINNEAPOLIS -- Bio-Techne Corporation (NASDAQ: TECH), a global provider of life science tools, reagents [...]

BOSTON -- SOPHiA GENETICS (NASDAQ: SOPH) and Myriad Genetics, Inc., (NASDAQ: MYGN) today announce a collaboration to advance new prostate cancer-specific genomic instability score (PrGIS) technology to support precision oncology approaches with AstraZeneca (LSE/STO/NYSE: AZN). PrGIS is a novel biomarker signature designed to assess chromosomal instability associated with homologous recombination deficiency (HRD) in prostate cancer patients. The [...]

The Endeavor® adds the fastest high-content cellular data generation to Ginkgo's around-the-clock research  PORTLAND, Ore. and BOSTON -- Araceli Biosciences and Ginkgo Bioworks (NYSE: DNA) today announced the integration of Araceli's Endeavor® high-content imaging instrument into Nebula, Ginkgo's autonomous lab in Boston. The Endeavor, the world's fastest high-content imaging system, brings cellular imaging with real-time analysis [...]

In a rare disease research dataset, SpliceAI2 identified 17% more disease-relevant variants compared to other splicing models Illumina's genomic AI models now collectively enable researchers to identify 2x as many variants with predicted biological impact SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) today introduced SpliceAI2, a new genomic AI model designed to address one of [...]